Candidiasis y Candida albicans

Yesid Fabian Mantilla-Florez, Eduardo Tuta-Quintero, Abraham Jose Brito-Rodriguez, Luis Carlos Clavijo-Moreno

Resumen


La candidiasis es una enfermedad micótica debida a levaduras pertenecientes al género Candida. Dentro del gran conjunto de microorganismos que colonizan al ser humano, Candida albicans es el agente etiológico más comúnmente detectado ya que habita como comensal en las superficies mucosas y la piel. C. albicans participa en procesos de fermentación de azúcares y asimilación de nutrientes, pero, en algunas ocasiones se relaciona con procesos patológicos. En los últimos años los avances tecnológicos y médicos; así como el aumento en la incidencia de infecciones por el virus de la inmunodeficiencia humana, el auge creciente de la terapia inmunomoduladora y el uso de antibióticos de amplio espectro durante largos períodos de tiempo se han convertido en los factores de riesgo más importantes para la creciente incidencia de infecciones por microorganismos del género Candida. Debido a esto, resulta imperativo el conocimiento de esta enfermedad y sus formas clínicas más importantes, así como el abordaje diagnóstico y el tratamiento actual; información que recolectamos en este documento para brindar una visión general sobre esta patología

Palabras clave


Candida albicans; Candidiasis; Inmunosupresión; Agentes antifúngicos.

Texto completo:

PDF

Referencias


Alarcón, P., González, M., & Castro, R. (2016). Rol de la microbiota gastrointestinal en la regulación de la respuesta inmune. Revista médica de Chile, 144(7), 910–916. https://doi.org/10.4067/s0034-98872016000700013

Alves De Medeiros, A. K., Lodewick, E., Bogaert, D. J. A., Haerynck, F., van Daele, S., Lambrecht, B., Bosma, S., Vanderdonckt, L., Lortholary, O., Migaud, M., Casanova, J. L., Puel, A., Lanternier, F., Lambert, J., Brochez, L., & Dullaers, M. (2016). Chronic and Invasive Fungal Infections in a Family with CARD9 Deficiency. Journal of Clinical Immunology, 36(3), 204–209. https://doi.org/10.1007/s10875-016-0255-8

Bassetti, M., Giacobbe, D. R., Vena, A., & Wolff, M. (2019). Diagnosis and Treatment of Candidemia in the Intensive Care Unit. Seminars in Respiratory and Critical Care Medicine, 40(04), 524–539. https://doi.org/10.1055/s-0039-1693704

Bhattacharya, S., Sae-Tia, S., & Fries, B. C. (2020). Candidiasis and Mechanisms of Antifungal Resistance. Antibiotics, 9(6), 312. https://doi.org/10.3390/antibiotics9060312

Brown, H., & Drexler, M. (2020). Improving the Diagnosis of Vulvovaginitis: Perspectives to Align Practice, Guidelines, and Awareness. Population Health Management, 23(S1), S-3. https://doi.org/10.1089/pop.2020.0265

Colombo, A. L., Júnior, J. N. D. A., & Guinea, J. (2017). Emerging multidrug-resistant Candida species. Current Opinion in Infectious Diseases, 30(6), 528–538. https://doi.org/10.1097/qco.0000000000000411

Cottier, F., & Hall, R. A. (2020). Face/Off: The Interchangeable Side of Candida Albicans. Frontiers in Cellular and Infection Microbiology, 9. https://doi.org/10.3389/fcimb.2019.00471

Cortés, J. A., Ruiz, J. F., Melgarejo-Moreno, L. N., & Lemos, E. V. (2020). Candidemia en Colombia. Biomédica, 40(1), 195–207. https://doi.org/10.7705/biomedica.4400

Dadar, M., Tiwari, R., Karthik, K., Chakraborty, S., Shahali, Y., & Dhama, K. (2018). Candida albicans - Biology, molecular characterization, pathogenicity, and advances in diagnosis and control – An update. Microbial Pathogenesis, 117, 128–138. https://doi.org/10.1016/j.micpath.2018.02.028

de Lorenzo, V. (2014). Pseudomonas aeruginosa:the making of a pathogen. Environmental Microbiology, 17(1), 1–3. https://doi.org/10.1111/1462-2920.12620

Dovnik, A., Golle, A., Novak, D., Arko, D., & Takač, I. (2015). Treatment of vulvovaginal candidiasis: a review of the literature. Acta Dermatovenerologica Alpina Pannonica et Adriatica, 24(1). https://doi.org/10.15570/actaapa.2015.2

Epelbaum, O., & Chasan, R. (2017). Candidemia in the Intensive Care Unit. Clinics in Chest Medicine, 38(3), 493–509. https://doi.org/10.1016/j.ccm.2017.04.010

Erdös, M., & Maródi, L. (2010). Dectin-1 Deficiency and Mucocutaneous Fungal Infections. New England Journal of Medicine, 362(4), 367–368. https://doi.org/10.1056/nejmc0911468

Freeman Weiss, Z., Leon, A., & Koo, S. (2021). The Evolving Landscape of Fungal Diagnostics, Current and Emerging Microbiological Approaches. Journal of Fungi, 7(2), 127. https://doi.org/10.3390/jof7020127

Humbert, L., Cornu, M., Proust-Lemoine, E., Bayry, J., Wemeau, J. L., Vantyghem, M. C., & Sendid, B. (2018). Chronic Mucocutaneous Candidiasis in Autoimmune Polyendocrine Syndrome Type 1. Frontiers in Immunology, 9. https://doi.org/10.3389/fimmu.2018.02570

Jafarian, H., Badiee, P., Ghasemmi, F., & Malek-Hosseini, S. A. (2019). Severe Cutaneous Candidiasis in a Liver Transplant Patient. Int J Organ Transplant Med, 10(1), 46–50.

Kadosh, D. (2019). Regulatory mechanisms controlling morphology and pathogenesis in Candida albicans. Current Opinion in Microbiology, 52, 27–34. https://doi.org/10.1016/j.mib.2019.04.005

Khalid, G. S., Hamrah, M. H., Ghafary, E. S., Hosseini, S., & Almasi, F. (2021). Antibacterial and Antimicrobial Effects of Xanthorrhizol in the Prevention of Dental Caries: A Systematic Review. Drug Design, Development and Therapy, Volume 15, 1149–1156. https://doi.org/10.2147/dddt.s290021

Khosravi, A., Mansouri, P., Saffarian, Z., Vahedi, G., & Nikaein, D. (2018). Chronic mucocutaneous candidiasis, a case study and literature review. Journal de Mycologie Médicale, 28(1), 206–210. https://doi.org/10.1016/j.mycmed.2018.02.004

Kinkela Devcic, M., Simonic-Kocijan, S., Prpic, J., Paskovic, I., Cabov, T., Kovac, Z., & Glazar, I. (2021). Oral Candidal Colonization in Patients with Different Prosthetic Appliances. Journal of Fungi, 7(8), 662. https://doi.org/10.3390/jof7080662

Klein, R. D., & Hultgren, S. J. (2020). Urinary tract infections: microbial pathogenesis, host–pathogen interactions and new treatment strategies. Nature Reviews Microbiology, 18(4), 211–226. https://doi.org/10.1038/s41579-020-0324-0

Leung, A. K., Lam, J. M., Leong, K. F., Hon, K. L., Barankin, B., Leung, A. A., & Wong, A. H. (2020). Onychomycosis: An Updated Review. Recent Patents on Inflammation & Allergy Drug Discovery, 14(1), 32–45. https://doi.org/10.2174/1872213x13666191026090713

Lipner, S. R., & Scher, R. K. (2019). Onychomycosis. Journal of the American Academy of Dermatology, 80(4), 853–867. https://doi.org/10.1016/j.jaad.2018.05.1260

Lisboa, C., Santos, A., Dias, C., Azevedo, F., Pina-Vaz, C., & Rodrigues, A. (2009). Candida balanitis: risk factors. Journal of the European Academy of Dermatology and Venereology, 24(7), 820–826. https://doi.org/10.1111/j.1468-3083.2009.03533.x

Millsop, J. W., & Fazel, N. (2016). Oral candidiasis. Clinics in Dermatology, 34(4), 487–494. https://doi.org/10.1016/j.clindermatol.2016.02.022

Mohamed, A. A., Lu, X. L., & Mounmin, F. A. (2019). Diagnosis and Treatment of Esophageal Candidiasis: Current Updates. Canadian Journal of Gastroenterology and Hepatology, 2019, 1–6. https://doi.org/10.1155/2019/3585136

Naglik, J. R., Gaffen, S. L., & Hube, B. (2019). Candidalysin: discovery and function in Candida albicans infections. Current Opinion in Microbiology, 52, 100–109. https://doi.org/10.1016/j.mib.2019.06.002

Nobile, C. J., & Johnson, A. D. (2015). Candida albicans Biofilms and Human Disease. Annual Review of Microbiology, 69(1), 71–92. https://doi.org/10.1146/annurev-micro-091014-104330

Odabasi, Z., & Mert, A. (2019). Candida urinary tract infections in adults. World Journal of Urology, 38(11), 2699–2707. https://doi.org/10.1007/s00345-019-02991-5

Ostrosky-Zeichner, L., & Al-Obaidi, M. (2017). Invasive Fungal Infections in the Intensive Care Unit. Infectious Disease Clinics of North America, 31(3), 475–487. https://doi.org/10.1016/j.idc.2017.05.005

Pappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., & Kullberg, B. J. (2018). Invasive candidisis. Nature Reviews Disease Primers, 4(1). https://doi.org/10.1038/nrdp.2018.26

Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., Zaoutis, T. E., & Sobel, J. D. (2015). Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 62(4), e1-e50. https://doi.org/10.1093/cid/civ933

Patil, A., & Majumdar, S. (2017). Echinocandins in antifungal pharmacotherapy. Journal of Pharmacy and Pharmacology, 69(12), 1635–1660. https://doi.org/10.1111/jphp.12780

Pereira, R., Santos Fontenelle, R., Brito, E., & Morais, S. (2020). Biofilm of Candida albicans: formation, regulation and resistance. Journal of Applied Microbiology, 131(1), 11–22. https://doi.org/10.1111/jam.14949

Polke, M., Hube, B., & Jacobsen, I. D. (2015). Candida Survival Strategies. Advances in Applied Microbiology, 139–235. https://doi.org/10.1016/bs.aambs.2014.12.002

Pristov, K., & Ghannoum, M. (2019). Resistance of Candida to azoles and echinocandins worldwide. Clinical Microbiology and Infection, 25(7), 792–798. https://doi.org/10.1016/j.cmi.2019.03.028

Puerta-Alcalde, P., Soriano, C., Soriano, A., & García-Vidal, C. (2018). Top-ten papers in fungal infection (2015–2017). Rev Esp Quimioter, 31, 32–34.

Spence D. (2010). Candidiasis (vulvovaginal). BMJ clinical evidence, 2010, 0815

Talapko, J., Juzbašić, M., Matijević, T., Pustijanac, E., Bekić, S., Kotris, I., & ŠKrlec, I. (2021). Candida albicans—The Virulence Factors and Clinical Manifestations of Infection. Journal of Fungi, 7(2), 79. https://doi.org/10.3390/jof7020079

Taudorf, E., Jemec, G., Hay, R., & Saunte, D. (2019). Cutaneous candidiasis – an evidence‐based review of topical and systemic treatments to inform clinical practice. Journal of the European Academy of Dermatology and Venereology, 33(10), 1863–1873. https://doi.org/10.1111/jdv.15782

Tchernev, G., Penev, P. K., Nenoff, P., Zisova, L. G., Cardoso, J. C., Taneva, T., Ginter-Hanselmayer, G., Ananiev, J., Gulubova, M., Hristova, R., Nocheva, D., Guarneri, C., Martino, G., & Kanazawa, N. (2012). Onychomycosis: modern diagnostic and treatment approaches. Wiener Medizinische Wochenschrift, 163(1–2), 1–12. https://doi.org/10.1007/s10354-012-0139-3

van de Veerdonk, F. L., & Netea, M. G. (2016). Treatment options for chronic mucocutaneous candidiasis. Journal of Infection, 72, S56-S60. https://doi.org/10.1016/j.jinf.2016.04.023

Vila, T., Romo, J. A., Pierce, C. G., McHardy, S. F., Saville, S. P., & Lopez-Ribot, J. L. (2016). Targeting Candida albicans filamentation for antifungal drug development. Virulence, 8(2), 150–158. https://doi.org/10.1080/21505594.2016.1197444

Wall, G., Montelongo-Jauregui, D., Vidal Bonifacio, B., Lopez-Ribot, J. L., & Uppuluri, P. (2019). Candida albicans biofilm growth and dispersal: contributions to pathogenesis. Current Opinion in Microbiology, 52, 1–6. https://doi.org/10.1016/j.mib.2019.04.001

White, P. L. (2019). Recent advances and novel approaches in laboratory-based diagnostic mycology. Medical Mycology, 57(Supplement_3), S259-S266. https://doi.org/10.1093/mmy/myy159

Yao, X. Y., Zhou, X. B., Zhang, W. G., Liu, B. Y., Wen, G. D., Zhang, J. Z., & Zhou, C. (2018). Candida balanitis with Hyperplastic Plaque Mimicking Vascular Neoplasm. Chinese Medical Journal, 131(10), 1253–1254. https://doi.org/10.4103/0366-6999.231514

Yoo, Y. J., Kim, A. R., Perinpanayagam, H., Han, S. H., & Kum, K. Y. (2020). Candida albicans Virulence Factors and Pathogenicity for Endodontic Infections. Microorganisms, 8(9), 1300. https://doi.org/10.3390/microorganisms8091300


Enlaces refback

  • No hay ningún enlace refback.


Bookmark and Share


Copyright (c) 2021 Boletín de Malariología y Salud Ambiental